Join Biotricity for Their Fourth Quarter Financial Update
Biotricity Inc. (OTCQB: BTCY) is excited to invite investors and stakeholders to its Fiscal 2025 Fourth Quarter Financial Results and Business Update Call. This eagerly anticipated event will take place shortly, where the company will share significant improvements in various key performance metrics. As a forward-thinking Technology-as-a-Service (TaaS) company, Biotricity continues to innovate within the healthcare landscape, showcasing advancements in remote monitoring and diagnostic solutions.
Key Highlights and Expectations
During the upcoming call, Biotricity's leadership team, including Founder and CEO Dr. Waqaas Al-Siddiq and CFO John Ayanoglou, will discuss the positive trajectory of the company’s financial performance. With a move towards achieving positive adjusted EBITDA, Biotricity is setting the stage for robust discussion points around operational efficiency and margin enhancements.
Event Details to Note
The call is scheduled for July 18, 2025, at 4:45 PM ET (1:45 PM PT). Investors can join by calling the toll-free number at 1-877-269-7751 or the international line at 1-201-389-0908. The details are designed for ease of access, allowing participants to enter the discussion confidently.
Accessing the Webcast
Interested participants can also access a live webcast of the event by visiting the provided link, available 15 minutes before the call. Note that the call will be in listen-only mode but will include a question-and-answer session, allowing shareholders to engage with the leadership directly.
The Future Landscape of Biotricity
Biotricity is not just enhancing its current frameworks but also reimagining the healthcare space by bridging gaps in remote monitoring and chronic care management. This crystal-clear commitment not only reassures existing patients and healthcare providers of Biotricity's value but also attracts new users seeking reliable solutions for chronic conditions.
Replay Information for Investors
A replay of the call will be made available approximately three hours after it concludes, ensuring that all interested parties can catch up on the developments discussed. The replay can be accessed through Biotricity's Investor page, maintaining transparency and openness with the investing community.
About Biotricity Inc.
As innovators, Biotricity Inc. stands at the forefront of healthcare technology, meticulously focusing on preventive and personal care through its sophisticated diagnostic and post-diagnostic solutions. Their mission revolves around comprehensive remote health monitoring designed for both medical and consumer markets, cementing their role as trusted partners in patient care.
Continuing Innovations and Growth
The insights expected from Biotricity will shed light on their strategies for future operations and potential new products. With plans aiming to enhance their existing offerings, the company is set to explore new avenues for growth and market expansion. Exciting times lie ahead as Biotricity embraces innovation during this transformative period.
Frequently Asked Questions
What is Biotricity's Fiscal 2025 Fourth Quarter Financial Results Call about?
The call will cover Biotricity's financial performance, operational efficiencies, and strategic discussions focusing on positive adjusted EBITDA.
Who will be speaking at the event?
Dr. Waqaas Al-Siddiq, Founder and CEO, along with CFO John Ayanoglou, will present during the call.
How can I access the call?
Investors can join via a toll-free number or through an online webcast link available 15 minutes prior to the call.
When is the call scheduled to occur?
The call is scheduled for July 18, 2025, at 4:45 PM ET.
How can I replay the call later?
A replay will be available approximately 3 hours post the live transmission, accessible via Biotricity’s website.
